C23H22N6O2
414.5 g/mol
APIWarning
Cyt387
CAS1056634-68-4
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Momelotinib, also known as Cyt387, is an ATP-competitive inhibitor of Janus kinases 1 and 2 (JAK1/JAK2). It is a benzamide derivative used as an active pharmaceutical ingredient in the production of treatments for myelofibrosis.
Pharmaceutical raw material for myelofibrosis therapyJAK1/JAK2 inhibitor in drug manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1056634-68-4
Related Compounds
StrongSame Parent
Momelotinib dihydrochloride
CAS1380317-28-1
pharmaceutical raw material
StrongSame Parent
Momelotinib dihydrochloride monohydrate
CAS1841094-17-4
pharmaceutical raw material
ReferenceSame Category
Acrivastine isomer Z
CAS1057138-89-2
pharmaceutical raw material
ReferenceSame Category
(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
CAS105813-13-6
pharmaceutical raw material
ReferenceSame Category
Nateglinide
CAS105816-04-4
pharmaceutical raw material
ReferenceSame Category
Ent-Nateglinide
CAS105816-05-5
pharmaceutical raw material
Referencesame scaffold
4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid
CAS945749-71-3
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide
InChIKey
ZVHNDZWQTBEVRY-UHFFFAOYSA-N
SMILES
C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N
Synonyms (22)
- EX-A260
- Momelotinib (USAN/INN)
- CYT 11387
- CYT387,CYT 11387
- Cyt387
- Momelotinib
- Momelotinib (CYT387)
- Momelotinib (CYT387,CYT-387)
- Ojjaara
- Omjjara
- SDCCGSBI-0654405.P001
- momelotinibum